GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » 10x Genomics Inc (MEX:TXG) » Definitions » Gross Margin %

10x Genomics (MEX:TXG) Gross Margin % : 70.16% (As of Sep. 2024)


View and export this data going back to 2021. Start your Free Trial

What is 10x Genomics Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. 10x Genomics's Gross Profit for the three months ended in Sep. 2024 was MXN2,095 Mil. 10x Genomics's Revenue for the three months ended in Sep. 2024 was MXN2,986 Mil. Therefore, 10x Genomics's Gross Margin % for the quarter that ended in Sep. 2024 was 70.16%.

Warning Sign:

10x Genomics Inc gross margin has been in long-term decline. The average rate of decline per year is -2.4%.


The historical rank and industry rank for 10x Genomics's Gross Margin % or its related term are showing as below:

MEX:TXG' s Gross Margin % Range Over the Past 10 Years
Min: 66.15   Med: 80.41   Max: 85.14
Current: 66.58


During the past 7 years, the highest Gross Margin % of 10x Genomics was 85.14%. The lowest was 66.15%. And the median was 80.41%.

MEX:TXG's Gross Margin % is ranked better than
74.23% of 617 companies
in the Healthcare Providers & Services industry
Industry Median: 41.13 vs MEX:TXG: 66.58

10x Genomics had a gross margin of 70.16% for the quarter that ended in Sep. 2024 => Durable competitive advantage

The 5-Year average Growth Rate of Gross Margin for 10x Genomics was -2.40% per year.


10x Genomics Gross Margin % Historical Data

The historical data trend for 10x Genomics's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

10x Genomics Gross Margin % Chart

10x Genomics Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Gross Margin %
Get a 7-Day Free Trial 75.18 80.44 84.89 76.69 66.15

10x Genomics Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Gross Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 62.18 62.93 65.89 68.07 70.16

Competitive Comparison of 10x Genomics's Gross Margin %

For the Health Information Services subindustry, 10x Genomics's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


10x Genomics's Gross Margin % Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, 10x Genomics's Gross Margin % distribution charts can be found below:

* The bar in red indicates where 10x Genomics's Gross Margin % falls into.



10x Genomics Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

10x Genomics's Gross Margin for the fiscal year that ended in Dec. 2023 is calculated as

Gross Margin % (A: Dec. 2023 )=Gross Profit (A: Dec. 2023 ) / Revenue (A: Dec. 2023 )
=6947.8 / 10502.426
=(Revenue - Cost of Goods Sold) / Revenue
=(10502.426 - 3554.646) / 10502.426
=66.15 %

10x Genomics's Gross Margin for the quarter that ended in Sep. 2024 is calculated as


Gross Margin % (Q: Sep. 2024 )=Gross Profit (Q: Sep. 2024 ) / Revenue (Q: Sep. 2024 )
=2094.9 / 2986.113
=(Revenue - Cost of Goods Sold) / Revenue
=(2986.113 - 891.203) / 2986.113
=70.16 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


10x Genomics  (MEX:TXG) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

10x Genomics had a gross margin of 70.16% for the quarter that ended in Sep. 2024 => Durable competitive advantage


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


10x Genomics Gross Margin % Related Terms

Thank you for viewing the detailed overview of 10x Genomics's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


10x Genomics Business Description

Traded in Other Exchanges
Address
6230 Stoneridge Mall Road, Pleasanton, CA, USA, 94588
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.